Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.
Pike Therapeutics has raised $100K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2023.
Pike Therapeutics is headquartered in Toronto, Canada.
Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.
Pike Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pike Therapeutics — Funding & Investors." VCBacked, August 31, 2023, https://www.vcbacked.co/company/pike-therapeutics. Accessed July 20, 2026.
VCBacked. (2023). Pike Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/pike-therapeutics
{{cite web |title=Pike Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pike-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated